Inhaled Isopropyl Alcohol Versus Placebo to Manage Nausea at Electronic Dance Music Festivals
NCT04307550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2025-04-09
Summary
BACKGROUND
Studies have shown that isopropyl alcohol inhalation is effective for the relief of nausea in the emergency department. A 2016 randomized controlled trial found that nasally inhaled isopropyl alcohol achieved better nausea relief compared to placebo during a 10-minute period. In 2018, another randomized controlled trial showed that nasally inhaled isopropyl alcohol with or without oral ondansetron provided greater relief for nausea than oral ondansetron alone.
QUESTION
In electronic dance music festival attendees, who present with nausea to the medical team, how does inhaled isopropyl alcohol compare with inhaled sterile saline (placebo) for self-reported nausea 10-minutes post-intervention?
METHODS
Canadian electronic dance music festival attendees who present with nausea to the medical team, will be recruited until sample size reaches at least 70. Inclusion criteria will be festival attendees aged 18+ with a complaint of nausea. Exclusion criteria will include known allergy to isopropyl alcohol, inability to inhale through the nares, inability to report level of nausea, or already have taken an anti-nauseant.
After obtaining consent, participants will be randomized into two study arms. Arm 1 will nasally inhale an isopropyl alcohol pad with 10 deep inhalations (intervention). Arm 2 will nasally inhale a sterile saline pad with 10 deep inhalations (placebo). The pad must be within 2cm from the nares to ensure delivery. According to a study in 2002, isopropyl alcohol pad inhalation, dosed at 3 inhalations every 5 minutes for 3 doses, was not significantly different than standard treatment for relief of nausea. 10 inhalations exceeds the 9-dose total reported in the paper, and a one-time bolus dose of 10 inhalations, for the population and festival context, is more feasible in terms of patient compliance and patient flow.
After randomization, participants will rate their nausea on a numeric response scale (0 to 10, where 0 is no nausea and 10 is "worst nausea imaginable"). 10-minutes post-inhalation (isopropyl alcohol or placebo), participants will be asked to rate their nausea again.
The primary outcome is self-reported nausea scores 10-minutes post-intervention. The secondary outcome is the presence or absence of any vomiting spells 10-minutes post-intervention, as well as the presence or absence of rescue-medication needed 10-minutes post-intervention.
Conditions
Interventions
- DRUG
-
Isopropyl alcohol
10 inhalations of an isopropyl alcohol pad
- OTHER
-
Placebo
10 inhalations of a sterile saline pad
Sponsors & Collaborators
-
Anthony Seto
lead OTHER
Principal Investigators
-
Anthony V Seto, MD · University of Calgary
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-12
- Primary Completion
- 2024-10-27
- Completion
- 2024-10-27
Countries
- Canada
Study Locations
More Related Trials
-
Mifepristone for the Prevention of Relapses of Alcohol Drinking
NCT02243709 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Endotoxin on Alcohol Consumption
NCT04527185 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185 ·Status: COMPLETED ·Phase: PHASE1
-
Interactive Effects of IV Ethanol and IV Nicotine
NCT01814410 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Bristol Imperial MDMA in Alcoholism Study
NCT04158778 ·Status: UNKNOWN ·Phase: PHASE1
-
Ketone Ester Intervention in Alcohol Use Disorder
NCT04616781 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
CBD for the Treatment of Alcohol Use Disorder
NCT04873453 ·Status: COMPLETED ·Phase: PHASE2
-
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
NCT04596267 ·Status: TERMINATED ·Phase: PHASE1
-
MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
NCT03033823 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel
NCT01531920 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Inhalation of Essential Oil on the Reduction of Inhalants Craving
NCT03296943 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
NCT03878316 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Combined Alcohol and Nitrous Oxide Intake - 15
NCT00000263 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
NCT02364947 ·Status: COMPLETED ·Phase: PHASE3
-
Psilocybin-assisted Therapy for Alcohol Use Disorder
NCT06444243 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Computer-Assisted Self-Administration of Ethanol
NCT00713492 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine for the Treatment for Alcohol Use Disorder in the ED
NCT05661669 ·Status: WITHDRAWN ·Phase: PHASE2
-
Alcohol and Neural Cardiovascular Control in Binge Drinkers
NCT03567434 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Alcohol Withdrawal and Dependence
NCT02903251 ·Status: COMPLETED ·Phase: PHASE3
-
Neural Mechanisms Underlying Alcohol Induced Disinhibition
NCT01097213 ·Status: COMPLETED
-
MAP4343 Treatment for Alcohol Use Disorder
NCT04157114 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
NCT03430180 ·Status: UNKNOWN ·Phase: PHASE2
-
Trials of Ventilation Assisted Substance Elimination Via the Lung - Ethanol (VASEL - Ethanol)
NCT04229732 ·Status: UNKNOWN ·Phase: NA